Showing results (1-10 of 1,154) with videos related to

Sort By:
Pageof 116
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|October 21, 2003
Sex, survival bias, and mortality following acute myocardial infarctionFelicita Andreotti, Elena Conti, Gaetano A Lanza, et al.
Atherosclerosis|May 20, 2015
Sex differences in mechanisms, presentation and management of ischaemic heart diseaseFilippo Crea, Irma Battipaglia, Felicita Andreotti
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 17, 2020
Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patientsMattia Galli, Felicita Andreotti, Italo Porto, et al.
Cytokine|March 12, 2005
Inflammation, genetics, and ischemic heart disease: focus on the major histocompatibility complex (MHC) genesItalo Porto, Antonio Maria Leone, Filippo Crea, et al.
Expert Opinion on Drug Safety|November 12, 2020
Safety and efficacy of P2Y<sub>12</sub> inhibitor monotherapy in patients undergoing percutaneous coronary interventionsMattia Galli, Davide Capodanno, Felicita Andreotti, et al.
European Heart Journal|September 7, 2005
Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patientsFelicita Andreotti, Luca Testa, Giuseppe G L Biondi-Zoccai, et al.
Giornale Italiano Di Cardiologia (2006)|May 25, 2012
[Pathophysiology of ischemic heart disease in women]Felicita Andreotti, Teresa Rio, Maura Gianmarinaro, et al.
Journal of Clinical Medicine|April 30, 2021
Precision Phenomapping of Acute Coronary Syndromes to Improve Patient OutcomesFelicita Andreotti, Adelaide Iervolino, Eliano Pio Navarese, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 19, 2021
Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trialsMattia Galli, Davide Capodanno, Stefano Benenati, et al.
The American Journal of Cardiology|June 15, 2007
Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromesLuca Testa, Giuseppe Biondi Zoccai, Italo Porto, et al.
Pageof 116